ByErika Edwards, Sara G. Miller, Patrick Smith and Keir Simmons
Preliminary results indicate a coronavirus vaccine being developed by the University of Oxford and AstraZeneca is safe and shows signs of inducing an immune response, according to early clinical trial results published Monday in the medical journal The Lancet.
Researchers with the study said the trial did not look at whether the vaccine prevents coronavirus infection, however. That's a question that will be answered in trials that are currently ongoing.
Early results in the trial found that it generated two "strong" immune responses: the production of both antibodies and T cells, which find and attack virus cells.
More: NBCNews.com